All In MedTech

FDA Clearance Tracker · K253261

Apollo Quattro (APQ-10M)

A 510(k) clearance means FDA found the device substantially equivalent to one already on the market. It is not an approval, and it is not a finding that the device works better than others.

Last checked: Nov 19, 2026Latest source record: Mar 13, 2026 (this decision)Source: openFDAMethods & limitations

510(k)

Decided

Mar 13, 2026

Substantially Equivalent

Time to decision

165 days

Received Sep 29, 2025. Calendar days, including time FDA spent waiting on the applicant.

Pathway

510(k)

Traditional

Device class

Class II

The decision

FDA number
K253261
Device name
Apollo Quattro (APQ-10M)
Applicant location
Suwon, KR
Received
Sep 29, 2025
Decided
Mar 13, 2026
Decision
Substantially Equivalent
Submission type
Traditional

Device type

Device class
Class II
Regulation
21 CFR 878.4400

Every decision under product code PBX

How new is this?

These are facts about FDA's records. They are not a judgment about the device.

  • It is not the first decision under product code PBX. The earliest in FDA's data is K122389, decided Nov 2, 2012.
  • It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.

Source documents

The predicate devices this clearance relied on are named in the summary document. We do not extract them yet.

Other decisions for Weero Co., Ltd.

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

1 more FDA decisions with a free account

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.